Risk factor analysis and clinical experience of treating red breast syndrome in acellular dermal matrix and implant-based breast reconstruction.

ABSTRACT:

Background

Red breast syndrome (RBS) is represented as idiopathic cutaneous erythema overlying the acellular dermal matrix (ADM) after implant-based breast reconstruction without other signs and symptoms of infection. Although a number of etiologies including lymphatic disruption, delayed hypersensitivity reaction to ADM, and residual DNA within ADM have been suggested for RBS, consensus regarding risk factors and treatment for RBS has been reached yet. Thus, the aim of this study was to find risk factors for RBS and introduce our experience of successful treatment of RBS.

Methods

A retrospective study was conducted for patients who underwent implant-based breast reconstruction using ADM from October 2018 to February 2021. Demographics, types of ADM used, reconstructive char

SUBMITTER: Lee HC 

PROVIDER: S-EPMC12004325 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature